Things are looking up in the cannabis sector in Canada, with legalization ready to take form in the spring, and Canadian cannabis stocks are reaping from the benefits.
A number of states in the US, and of course Canada as mentioned above, are in various phases of legalization for both medical and recreational marijuana use, making the market confusing for new investors. What’s more, the pot bubble of 2014 serves as a good reminder for investors to do careful due diligence on any potential cannabis investment. Still, there are good opportunities out there for interested investors willing to do their research.
With that in mind, here’s a look at a few publicly traded Canadian marijuana stocks. The list includes cannabis and hemp focused stocks listed on Canadian exchanges.
Canopy Growth (TSX:WEED)
One of the larger Canadian marijuana stocks, Canopy holds producers Tweed and Bedrocan under its umbrella. Tweed’s production facility is located in the old Hershey factory in Smith Falls, Ontario. Its breeding facility was recently completed in September 2016. The company believes the state-of-the art facility is the first of its kind and will form the foundation of new Canadian-bred genetics.
Near the end of May 2016, Canopy Growth announced it would be expanding into Australia through a partnership with AusCann Group Holdings. The company also announced on September 15, 2016 that it launched its first DNA Genetics strain, Lemon Skunk, in its Tweed store. Tweed has also launched a new seed breeding area which will serve as a massive accelerator towards innovating product development and expanding quality and variety.
One of the first medical cannabis producers in Canada to be licensed under MMPR, Mettrum Health is a vertically integrated provider of cannabis products. It operates three facilities in Ontario with an annual production capacity of 12,000 kilograms. Mettrum offers a range of products in both whole-bud and extract forms.
As mentioned above, Mettrum and Canopy Growth entered into an agreement wherein Canopy would acquire Mettrum. In January 2017, Mettrum Health announced it had acquired Bodystream Cannabis Clinic network, which includes 14 medical cannabis clinics located across Ontario.
As its name suggests, OrganiGram specializes in producing organically grown medical marijuana. The company is licensed under MMPR, and has a production facility located in Moncton, New Brunswick. In 2016, Organigram closed a $10 million bought deal financing, and it announced that it would be acquiring 10 acres of adjoining property to its current location in Moncton. The transaction will occur in late September.
The company also entered into an exclusive product development and distribution agreement with TGS International in September 2016. TGS is an affiliate of the Green Solution, a major Colorado marijuana dispensary, and will provide consulting for the development and operation for OrganiGram’s new production and processing facility.
In January, Organi announced it had acquired additional lands and premises adjacent to its existing property in Moncton.
Also licensed under MMPR, Aphria is located in Learnington Ontario, at “Canada’s southernmost point.” Last June, the company announced it expects to more than double its growing capacity—the company’s board approved in September a $24.5 million project increasing its greenhouse square footage from 100,000 to 300,000 square feet, expected to be completed later this year. The company expects that the expansion will be able to bump growing capabilities from 5,500 kilograms to 18,000 kilograms annually.
Aphria is also in the midst of completing its previously disclosed 57,000 square foot Part II expansion, is on target for full crop rotation by June 2017. In January, the company reported a 19 percent growth in quarterly revenue. In early February, the company announced that it moved from the TSX Venture Exchange to the TSX Exchange. A week later, Aphria announced a $50 million bought deal financing.
Aurora Cannabis (TSXV:ACB)
Aurora’s production facilities are located in Mountain View County, Alberta, near the Rocky Mountains. The company aims to “produce the cleanest, safest medical cannabis available on the market,” and all of its strains are currently offered at $8 per gram.
On September 2, 2016, Aurora surpassed 7,700 active registered patients, just under eight months after the Company’s first sale of product. In November 2016, the company announced construction had begun on its 800,000 square foot Aurora Sky expansion, with a target completion for October 2017. In December, Aurora announced the production facility would be located at the Edmonton International Airport. Subject to conditions, the company notes it will lease 30 acres from the Edmonton Regional Airports Authority.
Naturally Splendid (TSXV:NSP)
Naturally Splendid has a slightly different focus—rather than being involved in the medical marijuana space, the company offers investors exposure to the hemp-based healthy foods and omega markets. It is the only publicly traded company in the world offering investors exposure in this area. Naturally Splendid also has a sister company listed on the OTC, Laguna Blends (OTCMKTS:LAGBF), which is focused on the nutritional health benefits of hemp.
In November, the company reported over $6.3 million in year-to-date revenue. More recently, Naturally Splendid announced it will be presenting an expanded line of CBD products at FOODEX in Japan in March.
Beleave’s current facility is 14,500 square feet, and has already been endorsed by the City of Hamilton Planning and Economic Development Department and plans to produce 550,000 grams of cannabis per year.
On January 12, the company completed its facility build out and upgraded its production equipment, which include cloud server storage and record retention scalability, surveillance equipment, lighting systems, among others.
Golden Leaf Holdings (CSE:GLH)
Listed in Canada but located in Oregon, Golden Leaf Holdings is focused on producing high quality cannabis oils. Currently, the company’s portfolio of brands is to meet the needs of patients, consumer and strategic partners.
On January 9, Golden Leaf announced it had received its recreational processor and wholesaler license for its Portland-based facility, as well its recreational retailer license for the Left Coast Connection dispensary.
Vodis Pharmaceuticals (CSE:VP)
Vodis has medical and recreational marijuana business operations in both Canada and the United States. Presently, Vodis is engaged in the application stage for a license to produce medical marijuana at its facility located in Delta, British Columbia through the Marihuana for Medical Purpose Regulation (“MMPR”) program. With facilities in BC and Washington State, Vodis is actively seeing expansion opportunities in other countries and US states.
In December 2016, the company announced its intentions to consolidate its share capital on a four old for one new basis. The consolidation will result in its outstanding common shares being reduced from 113,842,580 to 28,460,645 common shares. In early February, Vodis announced that its tenant, Our Church International, received official Phase 2 expansion approval by the Washington State Liquor and Cannabis Board.
THC Biomed (CSE:THC)
Located in Kelowna BC, THC BioMed has been granted permission to conduct research and development for scientific purposes with medicinal marijuana. The company provides scientific and biotechnical services to current and potential licensed producers under MMPR. In May 2016, Health Canada granted TCH BioMed a license to produce fresh marijuana, cannabis oil and cannabis resin.
In December 2016, Health Canada issued the company an amendment to sell starting materials–meaning marijuana plants–and grants, as well as plans to expand its facilities.
Cronos Group (TSXV:MJN)
The Cronos Group rebranded from PharmaCan to become Cronos Group in October 2016, with a vision to become Canada’s first bi-coastal licensed producer with interests in five licensed producers and three licensed applicants.
Cronos Group owns 100 percent interest of Peace Naturals, a company licensed to produce and sell medical marijuana, and also cultivate cannabis oil. On January 11, the company was granted its second Health Canada sales license through its wholly-owned subsidiary, Zone Produce. In February, the company announced a $15 million bought deal with Eight Capital.
Calyx Bio-Ventures (TSXV:CYX)
Calyx is an agri-tech company which owns a portfolio of proprietary intellectual property with applications in crop enhancement, as well as a software platform tailored to the advanced indoor agriculture sector.
In October 2016, the company announced that its wholly-owned subsidiary, Cannigistics Agri-Solutions, launched its first consumer facing cloud based off the company’s FocusPoint Software Platform.
Abattis Bioceuticals (CSE:ATT)
Abattis Bioceuticals is a vertically integrated biotechnology company focused on natural health products, including cannabis. The company develops natural health products and conducts research and development for the pharmaceutical, nutraceutical, bioceutical and cosmetic markets.
Emerald Health Botanicals (TSXV:EMH)
Emerald Health Botanicals, previously Emerald Health therapeutics, is a licensed medical marijuana producer under MMPR. As a federal research grant recipient, the company conducts research and development into the characterization of cannabis strains and cultivation technologies. It also collaborates with academic and medical research to help gain further understanding of the effect of cannabis on humans.
In November 2016, the company announced plans to lease 32 acres of agricultural land reserve lands around Vancouver, BC.
Tinley Beverage (CSE:TNY)
Tinley Beverage is the producer of Hemplify, a drinkable vitality supplement containing hemp extract made from the stalk of industrial hemp. The vegan, sugar free drink is a source of electrolytes, vitamins and Omega 3 fatty acids. The company reported receiving its first orders for Hemplify products on March 10, 2016. In August 2016 the company launched its web store at www.drinkhemplify.com and listed its flagship “Hemplify” product for sale on Amazon.com.
In November 2016, Tinley announced it had issued a purchase order for its next back of Hemplify products, and noted it is now available in over 100 stores, mostly in California.
On the technology side of things, Cannabix technologies is developing a breathalyzer that detects THC for use by law enforcement.
On September 16, 2016, Cannabix entered into a licence agreement for the patent and development of its breathalyzer, partnering with the University of Florida. Cannabix issued the university 603,870 common shares as part of the agreement, which provides exclusive worldwide rights in the area of breath analysis of controlled substances. Then on October 19, 2016, the company announced the development of a beta 2.0 marijuana breathalyzer.
More recently, the company provided another update on the marijuana breathalyzer development, noting it is progressing and expects to begin pre-trial live subject testing in March.
Puf Ventures (CSE:PUF)
Puf Ventures has a diversified portfolio of assets in the Canadian marijuana sector. It owns a passive, non-controlling interest in AAA Heidelberg, which is focused on using all-natural nutrients to grow healthy, pest free plants.
AAA Heidelberg has had an MMPR application pending with Health Canada since 2013. Other ventures the company has invested in include 1313 Cigs, VapeTronix, and Weed Beacon. In late January, the company announced it had recommenced its development of the WeedBacon platform.
True Leaf Pet (CSE:MJ)
Canada-based True Leaf is focused on the production of hemp-based functional dog chews. In August 2016, the company secured the first order for its True Hemp pet products with Pets Corner, the second largest pet store chain in the United Kingdom. The store will sell the product in all of its 174 stores. The sale also means that True Hemp is now generating revenue on two continents – North America and Europe. “We’re on our way to becoming a truly global brand,” said CEO Darcy Bomford.
In January 2017, True Leaf completed the purchase of an animal-care product company, OregaPet, which produces medicinal products for animals. In February, True Leaf Pet announced that it had entered into an agreement with Liberty Premium Pet Products in New Zealand to distribute dog chews in retail stores across the country.
Maple Leaf Green World (TSXV:MGW)
Maple Leaf Green World is involved in a number of different projects around the globe. In California, the company is joint-ventured with a non-profit collective for a growing facility. The company is also involved in an eco-agriculture venture in China, focused on growing value-added tree seedlings.
On January 4, Maple Leaf announced it had received notice from Health Canada that its application to become a licensed producer under the Access to Cannabis for Medical Purposes Regulations, and is now preparing their Telkwa, BC facility with the a goal of preparing for a pre-license inspection by Health Canada. At the end of January, the company announced it had secured a site for a facility in Nevada. Then in February, the company announced its intentions to raise $5 million.
Supreme Pharmaceuticals (CSE:SL)
Located in Kincardine, Ontario, the company’s federally approved medical marijuana company, 7ACRES, cultivates medical marijuana on a greenhouse cost base. Along with 24 other companies, Supreme received its Federal MMPR license in March of 2016.
In December 2016, Supreme announced it had closed a $55 million offering, with the intention to use the net proceeds to expand its hybrid greenhouse facility in Kincardine.
Wildflower Marijuana (CSE:SUN)
Working exclusively in Washington State, Wildflower Marijuana lists in Canada, with a focus on developing and designing products in the cannabis sector. In December 2016, the company signed a digital media agreement, which includes an overall marketing strategy.
Tetra Bio-Pharma (CSE:TBP)
Tetra Bio-Pharma is focused on combining traditional methods of medicinal cannabis use together with scientific validation for inclusion in the existing bio pharma industry.
In that regard, the company announced in January that had appointed Dr. Gilles Chamberland to its scientific and clinical advisory board. Then in February, Tetra Bio-Pharma announced it had received approval from Health Canada for its Phase I clinical study of smoked cannabis.
Marapharm Ventures (CSE:MDM)
Marapharm Ventures has two operations in British Columbia and, through its wholly-owned subsidiary, Marapharm Inc, it has applied to Health Canada to become a licensed producer under the MMPR. The company’s initial facility–a proposed 22,000 square feet area –will be on an 11-acre site in Kelowna.
Marapharm has also purchased land in Las Vegas for the purpose of building a facility that will host three medical marijuana licenses. What’s more, the company also has the opportunity in Washington to lease a facility to a tier 3 license holder.
On January 11, Marapharm announced it had entered into a subscription agreement to acquire 5 million 18 month share purchase warrants of Veritas Pharma (CSE:VRT) for a total of $250,000. February, however, has been a busy month for the company: on February 14, it announced it had entered into an agreement to purchase 13.6 acres of land and buildings in Washington; on February 20, Marapharm announced an acquisition in California, and then on February 21 the company announced an expansion of its cannabis delivery service.
Valens GroWorks (CSE:VGW)
Located in British Columbia’s Okanagan Valley, Valens GroWorks is a “rapidly emerging” with a focus on cannabis cultivation and research.
As of January 13, 2017, the company has completed the licensing inspection by the Regional Inspectorate of the Office of Controlled Substances of Health Canada. This includes the final inspection of the company’s wholly-owned subsidiary, Valens Agritech’s 17,000 square foot facility in Kelowna.
Liberty Leaf (CSE:LIB)
Liberty Leaf has the objective to be at the forefront of the medicinal and recreational cannabis industry. Located in Vancouver, the company signed a memorandum of understanding in November 2016 to acquire a interest in Oakland, California, a cannabis cultivation product manufacturer license holder. In early February, Liberty Leaf announced it had signed a letter of intent to acquire a 27.5 percent interest in Gr8 Track, a private California company licensed to produce medicinal cannabis.
Emblem is a licensed producer in Canada, currently using the latest in indoor grow science. The company’s new facility located in Ontario, was designed with a purpose to cultivate and cure cannabis for medicinal use. Emblem given the go-ahead in December 2016 from Health Canada to begin production of cannabis oil.
In January 2017, the company announced a $10 million special warrant bought deal financing with PI Financial.
CannaRoyalty puts together its platform of holdings through royalty agreements, equity interests, convertible debt and licensing agreements across Canada and the US. For CannaRoyalty, February has also been a busy month: on February 9, it announced it had reached 30 percent revenue with Oregon Processor Rich Extracts. Then on February 13, the company announced the 20 percent acquisition of Anandia Labs. By February 15, the company had closed a $15 million bought deal offering.
MYM Nutraceuticals (CSE:MYM)
MYM Nutraceuticals is a bio-pharmaceutical company and distributor of medical marijuana. It has applied to Health Canada for a production license under MMPR, and considers itself well prepared for distribution of medical marijuana, and a growing facility property.
On February 22, the company announced it had closed the acquisition of an inspection-stage licensed producer application, Sublime Culture.
This article has been updated since its original publication on June 13, 2016.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Jocelyn Aspa, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Mettrum Health, Naturally Splendid and Maple Leaf Green World are clients of the Investing News Network. This article is not paid-for content.